The goal of this research is to understand the function of calmyrin, a myristoylated calcium-binding protein that interacts with the Alzheimer's disease related protein, presenilin-2 (PS2). Our preliminary data suggest calmyrin is a calcium sensor: calcium binding triggers a large conformational change in the protein. We believe that the calcium-induced change in calmyrin conformation is important for facilitating its dynamic intracellular targeting and binding to proteins, such as PS2. We found overexpression of calmyrin induces calcium dysregulation and apoptosis. However, the mechanism(s) by which calmyrin induces calcium dysregulation and apoptosis is not known. Calmyrin shares highest homology with calcineurin B, the regulatory subunit of protein phosphatase 2B (calcineurin). In a yeast two-hybrid screen, we isolated calmitase, a putative serine phosphatase. Our preliminary results suggest that calmitase might be analogous to calcineurin, in that it could be the catalytic phosphatase component that is regulated by calmyrin. In accord with this hypothesis, we found calmyrin binds calmitase in a calcium-dependent manner and that co-expression of calmyrin and calmitase results in a dramatic alteration in calmitase localization in the nucleus and stimulates nuclear import of an NFATc-GFP reporter. We also found that transgenic expression of an MSV-driven calmyrin construct causes alopecia and premature death in mice. We believe that calmyrin is an important protein and propose to use a multi-pronged approach to characterize calmyrin and calmitase functions. We propose four specific aims:
Aim 1, to determine the role of calmyrin in cell function.
Aim 2, to characterize and determine the function of calmitase.
Aim 3, to characterize MSV-calmyrin transgenic mice.
Aim 4, to generate mice that are disrupted of the calmyrin gene in specific organs and tissues. The results obtained from the proposed research will lead to a better understanding of calmyrin in cells and organisms, and ultimately, its role in health and disease

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
7R01AG016839-11
Application #
8415709
Study Section
Special Emphasis Panel (ZRG1-MDCN-A (08))
Program Officer
Wise, Bradley C
Project Start
2000-02-01
Project End
2012-04-30
Budget Start
2012-03-01
Budget End
2012-04-30
Support Year
11
Fiscal Year
2009
Total Cost
$157,454
Indirect Cost
Name
University of Maryland Baltimore
Department
Miscellaneous
Type
Schools of Medicine
DUNS #
188435911
City
Baltimore
State
MD
Country
United States
Zip Code
21201
Rothenberg, Cara; Srinivasan, Deepa; Mah, Leann et al. (2010) Ubiquilin functions in autophagy and is degraded by chaperone-mediated autophagy. Hum Mol Genet 19:3219-32
Wang, Hongmin; Lim, Precious J; Karbowski, Mariusz et al. (2009) Effects of overexpression of huntingtin proteins on mitochondrial integrity. Hum Mol Genet 18:737-52
Lim, Precious J; Danner, Rebecca; Liang, Jing et al. (2009) Ubiquilin and p97/VCP bind erasin, forming a complex involved in ERAD. J Cell Biol 187:201-17
Wang, Hongmin; Lim, Precious J; Yin, Chaobo et al. (2006) Suppression of polyglutamine-induced toxicity in cell and animal models of Huntington's disease by ubiquilin. Hum Mol Genet 15:1025-41
Ford, Diana L; Monteiro, Mervyn J (2006) Dimerization of ubiquilin is dependent upon the central region of the protein: evidence that the monomer, but not the dimer, is involved in binding presenilins. Biochem J 399:397-404
Massey, Leann K; Mah, Alex L; Monteiro, Mervyn J (2005) Ubiquilin regulates presenilin endoproteolysis and modulates gamma-secretase components, Pen-2 and nicastrin. Biochem J 391:513-25
Zhu, Jingsong; Stabler, Stacy M; Ames, James B et al. (2004) Calcium binding sequences in calmyrin regulates interaction with presenilin-2. Exp Cell Res 300:440-54
Mah, A L; Perry, G; Smith, M A et al. (2000) Identification of ubiquilin, a novel presenilin interactor that increases presenilin protein accumulation. J Cell Biol 151:847-62
Janicki, S M; Stabler, S M; Monteiro, M J (2000) Familial Alzheimer's disease presenilin-1 mutants potentiate cell cycle arrest. Neurobiol Aging 21:829-36